We are live on ! Find out more
KCM

KRS Capital Management Portfolio holdings

AUM $215M
1-Year Est. Return 69.3%
This Fund
S&P 500
This Quarter Est. Return
+12.48%
1 Year Est. Return
+69.3%
3 Year Est. Return
+232.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$117M
AUM Growth
–
Cap. Flow
+$116M
Cap. Flow %
99.71%
Top 10 Hldgs %
34.8%
Holding
400
New
398
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$11.4M
2
NVDA icon
NVIDIA
NVDA
+$6.7M
3
AMD icon
Advanced Micro Devices
AMD
+$4.37M
4
FTNT icon
Fortinet
FTNT
+$3.79M
5
META icon
Meta Platforms (Facebook)
META
+$2.71M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 46.32%
2 Healthcare 12.86%
3 Consumer Discretionary 9.76%
4 Financials 7.49%
5 Communication Services 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPRX icon
376
Royalty Pharma
RPRX
$25.3B
$3K ﹤0.01%
+100
New +$3.88K
SCHV
377
Schwab US Large-Cap Value ETF
SCHV
$16.1B
$3K ﹤0.01%
+141
New +$3.34K
VWO icon
378
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$3K ﹤0.01%
+67
New +$3.38K
XLK icon
379
State Street Technology Select Sector SPDR ETF
XLK
$123B
$3K ﹤0.01%
+42
New +$3.46K
API
380
Agora
API
$366M
$1K ﹤0.01%
+100
New +$2.22K
CBRL icon
381
Cracker Barrel
CBRL
$1.3B
$1K ﹤0.01%
+8
New +$1.07K
EWX icon
382
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$691M
$1K ﹤0.01%
+28
New +$1.66K
HYG icon
383
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$1K ﹤0.01%
+18
New +$1.56K
IP icon
384
International Paper
IP
$21.9B
$1K ﹤0.01%
+27
New +$1.33K
SAIC icon
385
Saic
SAIC
$5.32B
$1K ﹤0.01%
+13
New +$1.13K
AQB icon
386
AquaBounty Technologies
AQB
$5.66M
$0 ﹤0.01%
+3
New +$193
BIIB icon
387
Biogen
BIIB
$30.4B
$0 ﹤0.01%
+3
New +$771
CRBP icon
388
Corbus Pharmaceuticals
CRBP
$183M
– –
0
– –
CRDL
389
Cardiol Therapeutics
CRDL
$163M
$0 ﹤0.01%
+100
New +$276
CRNT icon
390
Ceragon Networks
CRNT
$202M
$0 ﹤0.01%
+125
New +$376
CRT
391
Cross Timbers Royalty Trust
CRT
$60.7M
$0 ﹤0.01%
+23
New +$296
GTX icon
392
Garrett Motion
GTX
$5.64B
$0 ﹤0.01%
+86
New +$634
PBYI icon
393
Puma Biotechnology
PBYI
$425M
$0 ﹤0.01%
+58
New +$252
RMR icon
394
The RMR Group
RMR
$329M
$0 ﹤0.01%
+5
New +$173
RMTI icon
395
Rockwell Medical
RMTI
$29.4M
$0 ﹤0.01%
+3
New +$161
SLVM icon
396
Sylvamo
SLVM
$1.61B
$0 ﹤0.01%
+2
New +$58
SQNS
397
Sequans Communications SA
SQNS
$42.4M
$0 ﹤0.01%
+6
New +$733
TAK icon
398
Takeda Pharmaceutical
TAK
$55.7B
$0 ﹤0.01%
+55
New +$772
WAB icon
399
Wabtec
WAB
$49.8B
$0 ﹤0.01%
+5
New +$459
WKHS icon
400
Workhorse Group
WKHS
$36.5M
– –
0
– –
12 13 14 15
16

Similar funds

VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
TSS
Taylor Securities Services Harrisburg, Pennsylvania $214M AUM
CMBA
C.M. Bidwell & Associates Honolulu, Hawaii $214M AUM 18.82% 1-Year Est. Return
IH
IES Holdings Houston, Texas $214M AUM

KRS Capital Management's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for KRS Capital Management, which disclosed 400 positions worth $117M. Its ten largest holdings account for 35% of the portfolio.

Its largest position is Apple: 71,916 shares worth $12.8M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, followed by Healthcare and Consumer Discretionary.

  • KRS Capital Management's largest Q4 2021 buy was Apple: 71,916 shares worth $12.8M.
  • KRS Capital Management's ten largest holdings make up 35% of its $117M portfolio in Q4 2021.
  • KRS Capital Management disclosed 400 positions in Q4 2021, its first 13F filing on record.

Based on KRS Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.